Introduction

Chronic wounds pose a significant burden on patients, society, and the health-care setup. Higher costs, protracted clinical course, and increased risk of complications necessitate identifying novel treatment modalities that hasten healing and wound closure.

Areas covered

This article covers newer available treatment modalities for chronic wounds, namely the dehydrated amniotic membrane products, biological skin substitutes, and similar therapies aimed at the healing of chronic non-healing wounds. It presents product description for Amniofix (dehydrated human amniotic/chorionic membrane) and its efficacy, compared to other similar products.

Expert opinion

In our experience and review of available literature, we expect Amniofix to offer wound care specialists with a more effective, easy-to-use, and convenient treatment modality for chronic wounds. Amniofix and other dHACM (dehydrated human amniotic/chorionic membrane) therapies reported faster and complete healing with lower complication rates, when compared to other similar products. These features encourage the use of Amniofix in Diabetic foot ulcers and Venous Leg Ulcers, besides other conditions such as plantar fasciitis.

中文翻译：

---

脱水人羊膜/绒毛膜（AMNIOFIX）在伤口愈合中的最新作用。

介绍

慢性伤口给患者，社会和卫生保健机构带来了沉重负担。更高的成本，延长的临床过程以及增加的并发症风险有必要确定加速愈合和伤口闭合的新型治疗方式。

覆盖区域

本文介绍了针对慢性伤口的较新的可用治疗方式，即脱水羊膜产品，生物皮肤替代品以及旨在治愈慢性非愈合伤口的类似疗法。与其他类似产品相比，它提供了有关Amniofix（脱水人羊膜/绒毛膜）的产品说明及其功效。

专家意见

根据我们的经验和现有文献的回顾，我们希望Amniofix为伤口护理专家提供针对慢性伤口的更有效，易于使用和方便的治疗方式。与其他类似产品相比，Amniofix和其他dHACM（脱水的人羊膜/绒毛膜脱水）疗法据报道能更快，更彻底地治愈，并发症发生率更低。这些功能鼓励在其他足底筋膜炎等疾病中，在糖尿病足溃疡和下肢静脉溃疡中使用Amniofix。